# Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/Obese Volunteers

> **NCT00728455** · PHASE1 · WITHDRAWN · sponsor: **Novo Nordisk A/S**

## Conditions studied

- Metabolism and Nutrition Disorder
- Obesity

## Interventions

- **DRUG:** NNC 0070-0002-0349
- **DRUG:** NNC 0070-0002-0349
- **DRUG:** NNC 0070-0002-0349
- **DRUG:** NNC 0070-0002-0349
- **DRUG:** NNC 0070-0002-0349
- **DRUG:** placebo
- **DRUG:** placebo
- **DRUG:** placebo
- **DRUG:** placebo
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00728455
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-07
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00728455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00728455, "Examination of the Safety and Tolerability of NNC 0070-0002-0349 in Overweight/Obese Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00728455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*